Call for Abstract

International Conference and Expo on Biopharmaceutics, will be organized around the theme “Explore the Challenges in Biopharmaceutics and Drug Delivery Systems”

Biopharma-2015 is comprised of 12 tracks and 50 sessions designed to offer comprehensive sessions that address current issues in Biopharma-2015.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Evolution of generic drugs
  • Track 1-2Patient Advocacy
  • Track 1-3Advanced drug kinetics
  • Track 1-4Recent technology in biopharmaceuticals
  • Track 1-5Role of Biogenomic in Emergency medicin
  • Track 2-1Process of drug discovery
  • Track 2-2Preclinical & clinical phases
  • Track 2-3Investigational new drug
  • Track 3-1Drug Repositioning: Novel approaches for existing drugs
  • Track 3-2Trends in marketing & approval
  • Track 3-3Biotechnology application in biopharmaceuticals
  • Track 3-4Biopharma Oncology Market & its future trends
  • Track 4-1Clinical development for investigational drugs
  • Track 4-2Advance tools to accelerate Pharmaceutical drug delivery
  • Track 4-3Recent Biopharmaceuticals in auto-immune diseases
  • Track 4-4Drug Discovery and Optimization
  • Track 4-5Global regulatory and ethical issues in biopharmaceuticals
  • Track 4-6Drug labelling techniques
  • Track 5-1Development & approval times for orphan drugs
  • Track 5-2Pharmacotherapy in tissue regeneration
  • Track 5-3Biowaiver approaches for new drug
  • Track 6-1Advancements in oral drug delivery
  • Track 6-2Transdermal drug delivery systeme
  • Track 6-3Targeted drug delivery
  • Track 6-4Control release drug delivery system
  • Track 7-1Small angle x-ray scattering(SWAXS)
  • Track 7-2Protein targeted using nucleosome binding surface
  • Track 7-3Peptides binding to modulate gene expression
  • Track 7-4Epigenetic agent
  • Track 8-1Bioequivalence criteria for inhaled corticosteroid
  • Track 8-2Enhanced oral bioavailability of hydrophobic drugs
  • Track 8-3Bioequivalence studies on various dose combinations
  • Track 9-1Application of nanoparticles in pulmonary diseases
  • Track 9-2Nano-tubes in medicine & health care
  • Track 9-3Advance combinations of nanoparticles
  • Track 9-4Role in cancer therapy
  • Track 9-5Solid-lipid nanoparticle (SLN) & nanostructures lipid carriers (NLC)
  • Track 9-6Significance in neurological disorder
  • Track 10-1Polymer hydrogel Nanoparticle & their networks
  • Track 10-2Role of Bioactive molecule
  • Track 10-3Polymer networks in hydrogel structures
  • Track 10-4Latest Naturel Polymer used for IPNs
  • Track 11-1Hepatic drug clearance
  • Track 11-2Pharmacokinetics & pharmacodynamics
  • Track 11-3Pharmacogenomics in elimination
  • Track 11-4Toxicology in pharmacological studies
  • Track 12-1Biopharmaceuticals studies of herbal drugs
  • Track 12-2Herbal Remedies: drug interactions and adverse effects
  • Track 12-3Clinical research and complimentary alternative medicine in herbal drugs
  • Track 12-4Interactions between herbal medicines and prescription drugs